Mengming Xia

2.4k total citations
21 papers, 400 citations indexed

About

Mengming Xia is a scholar working on Molecular Biology, Plant Science and Pharmacology. According to data from OpenAlex, Mengming Xia has authored 21 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Plant Science and 5 papers in Pharmacology. Recurrent topics in Mengming Xia's work include Pharmacogenetics and Drug Metabolism (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Mengming Xia is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Mengming Xia collaborates with scholars based in China, Germany and United Kingdom. Mengming Xia's co-authors include Zoran Nikoloski, Guoxin Hu, Dabing Zhang, David Twell, Dabing Zhang, Yang Lv, Bo Cui, Jianxin Shi, Jing Wang and Sheng Quan and has published in prestigious journals such as Scientific Reports, BioMed Research International and Current Medicinal Chemistry.

In The Last Decade

Mengming Xia

18 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengming Xia China 11 196 175 69 55 35 21 400
Hina Iqbal India 12 119 0.6× 126 0.7× 90 1.3× 39 0.7× 20 0.6× 41 454
Dechao Tan Macao 14 208 1.1× 70 0.4× 120 1.7× 60 1.1× 31 0.9× 17 460
Mingquan Wu China 13 238 1.2× 91 0.5× 147 2.1× 41 0.7× 47 1.3× 36 531
Huaixue Mu China 10 180 0.9× 102 0.6× 53 0.8× 39 0.7× 29 0.8× 21 357
Aki Kijima Japan 14 195 1.0× 200 1.1× 36 0.5× 16 0.3× 18 0.5× 40 461
T Matsumoto Japan 12 223 1.1× 215 1.2× 63 0.9× 22 0.4× 24 0.7× 30 500
Xiyao Wang China 16 272 1.4× 264 1.5× 34 0.5× 20 0.4× 18 0.5× 54 678
Jiazhong Cai China 12 178 0.9× 69 0.4× 49 0.7× 19 0.3× 28 0.8× 23 323
Claudia Luckert Germany 12 197 1.0× 97 0.6× 120 1.7× 18 0.3× 42 1.2× 22 593
Agula Bo China 6 283 1.4× 149 0.9× 74 1.1× 11 0.2× 16 0.5× 11 463

Countries citing papers authored by Mengming Xia

Since Specialization
Citations

This map shows the geographic impact of Mengming Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengming Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengming Xia more than expected).

Fields of papers citing papers by Mengming Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengming Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengming Xia. The network helps show where Mengming Xia may publish in the future.

Co-authorship network of co-authors of Mengming Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Mengming Xia. A scholar is included among the top collaborators of Mengming Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengming Xia. Mengming Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yu, et al.. (2025). SEMI-SUPERVISED WHEAT EAR DETECTION ALGORITHM BASED ON THE MODIFIED YOLOv8. INMATEH Agricultural Engineering. 630–639.
2.
Xia, Mengming, et al.. (2024). The Pharmacokinetic Interaction of Tirabrutinib with Voriconazole,Itraconazole, and Fluconazole in SD Rats by UPLC-MS/MS. Current Medicinal Chemistry. 31(34). 5612–5619.
3.
Xia, Mengming, et al.. (2024). An innovative UPLC-MS/MS method for the quantitation and pharmacokinetics of eupafolin in rat plasma. Journal of Chromatography B. 1245. 124272–124272.
4.
Xia, Mengming, Yu Wang, Peiwu Geng, et al.. (2023). Evaluation of the inhibitory effect of azoles on pharmacokinetics of lenvatinib in rats both in vivo and in vitro by UPLC‐MS/MS. Thoracic Cancer. 14(33). 3331–3341. 3 indexed citations
5.
Wang, Shuanghu, Mengming Xia, Yu Wang, et al.. (2023). Inhibitory effect of Schisandrin on the pharmacokinetics of poziotinib in vivo and in vitro by UPLC‐MS/MS. Thoracic Cancer. 14(14). 1276–1285. 1 indexed citations
6.
Wang, Wanxia, Ping Jiang, Mengming Xia, et al.. (2017). Increased Oxidative Damage of RNA in Early‐Stage Nephropathy in db/db Mice. Oxidative Medicine and Cellular Longevity. 2017(1). 2353729–2353729. 6 indexed citations
7.
Zhao, Zhenying, et al.. (2016). Gene expression profiling reveals genes and transcription factors associated with dilated and ischemic cardiomyopathies. Pathology - Research and Practice. 213(5). 548–557. 16 indexed citations
8.
Zhang, Hui, Tao Wang, Yijia Wang, et al.. (2016). Inhibition of UDP-Glucuronosyltransferase (UGT) Isoforms by Arctiin and Arctigenin. Phytotherapy Research. 30(7). 1189–1196. 7 indexed citations
9.
Xia, Mengming, et al.. (2015). Young Genes out of the Male: An Insight from Evolutionary Age Analysis of the Pollen Transcriptome. Molecular Plant. 8(6). 935–945. 60 indexed citations
10.
Xia, Mengming, X.‐Y. Zhou, Ping Jiang, et al.. (2015). Analysis of the oxidative damage of DNA, RNA, and their metabolites induced by hyperglycemia and related nephropathy in Sprague Dawley rats. Free Radical Research. 49(10). 1199–1209. 11 indexed citations
11.
Wang, Zhe, Li Wang, Mengming Xia, et al.. (2015). Pharmacokinetics Interaction between Imatinib and Genistein in Rats. BioMed Research International. 2015. 1–7. 10 indexed citations
12.
Wang, Zhe, Wei Sun, Li Wang, et al.. (2014). Inhibitory effects of curcumin on activity of cytochrome P450 2C9 enzyme in human and 2C11 in rat liver microsomes. Drug Development and Industrial Pharmacy. 41(4). 613–616. 43 indexed citations
13.
Hu, Chaoyang, Jianxin Shi, Sheng Quan, et al.. (2014). Metabolic variation between japonica and indica rice cultivars as revealed by non-targeted metabolomics. Scientific Reports. 4(1). 5067–5067. 150 indexed citations
14.
Chen, Mengchun, Hui Jin, Mengming Xia, et al.. (2014). Effects of Cytochrome P450 2C9 Polymorphism on Bosentan Metabolism. Drug Metabolism and Disposition. 42(11). 1820–1825. 16 indexed citations
15.
Xia, Mengming, Mengchun Chen, Bingqing Liang, et al.. (2014). Effect of CYP2C9 genetic polymorphism on the metabolism of flurbiprofenin vitro. Drug Development and Industrial Pharmacy. 41(8). 1363–1367. 21 indexed citations
16.
Wang, Li, Zhe Wang, Mengming Xia, et al.. (2014). Inhibitory effect of silybin on pharmacokinetics of imatinib in vivo and in vitro. Canadian Journal of Physiology and Pharmacology. 92(11). 961–964. 8 indexed citations
17.
Xia, Mengming, Haiyun Wang, Mengchun Chen, et al.. (2014). The role of CYP2C9 genetic polymorphisms in the oxidative metabolism of diclofenac in vitro.. PubMed. 69(12). 898–903. 10 indexed citations
18.
Xu, Tao, Jun Luo, Peiwu Geng, et al.. (2013). The Effect of Apigenin on Pharmacokinetics of Imatinib and Its Metabolite N-Desmethyl Imatinib in Rats. BioMed Research International. 2013. 1–6. 16 indexed citations
19.
Xia, Mengming, Huayong Xu, Zoe A. Wilson, et al.. (2012). PMRD: a curated database for genes and mutants involved in plant male reproduction. BMC Plant Biology. 12(1). 215–215. 19 indexed citations
20.
Xia, Mengming, Toshiyuki Kudo, & Shizuyo Sutou. (1996). Sexing of Bovine Embryos with Male-Specific Repetitive DNA by Polymerase Chain Reaction: Characterization and Mapping of Bovine Male-Specific and Gender-Neutral Repetitive DNA.. Journal of Reproduction and Development. 42(2). 125–131. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026